Van de Westerlo Els: Difference between revisions
From Bioblast
No edit summary |
Β |
||
Line 15: | Line 15: | ||
== Participated at == Β | == Participated at == Β | ||
::::* [[MiPNet28.02_IOC162_Schroecken_AT| IOC162 Schroecken AT]] | |||
{{Labelingperson}} | {{Labelingperson}} |
Latest revision as of 14:26, 16 October 2023
Name | Van de Westerlo Els, |
---|---|
Institution | Radboud University Nijmegen Medical Centre
Dept. of Medical BioSciences (MBS) |
Address | Geert Grooteplein 26 (route 286), 6500 |
City | Nijmegen |
State/Province | |
Country | NL |
[email protected] | |
Weblink | |
O2k-Network Lab | NL Nijmegen Koopman WJH |
Participated at
Labels:
Publications
Add references to your publications
Abstracts
Published | Reference | |
---|---|---|
Koopman 2022 Abstract Bioblast | 2022 | 7.7. Β«10+5Β» Bulthuis EP, Einer C, Distelmaier F, Groh L, van Emst-de Vries SE, van de Westerlo E, van de Wal M, Wagenaars J, Rodenburg RJ, Smeitink JAM, Riksen NP, Willems PGHM, Adjobo-Hermans MJW, Zischka H, Koopman Werner JH (2022) The decylTPP mitochondria-targeting moiety lowers electron transport system supercomplex levels in primary human skin fibroblasts. Bioblast 2022: BEC Inaugural Conference. In: https://doi.org/10.26124/bec:2022-0001 |